3/20
11:02 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/20
11:02 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/20
10:06 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
3/20
10:06 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
3/18
08:08 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
3/18
08:08 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
3/17
04:34 pm
bpmc
Blueprint Medicines initiated with an Outperform at Wolfe Research
Low
Report
Blueprint Medicines initiated with an Outperform at Wolfe Research
3/17
04:34 pm
bpmc
Blueprint Medicines initiated with an Outperform at Wolfe Research
Low
Report
Blueprint Medicines initiated with an Outperform at Wolfe Research
3/17
07:26 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/17
07:26 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/17
03:43 am
bpmc
Blueprint Medicines initiated with a Buy at Jefferies
Low
Report
Blueprint Medicines initiated with a Buy at Jefferies
3/17
03:43 am
bpmc
Blueprint Medicines initiated with a Buy at Jefferies
Low
Report
Blueprint Medicines initiated with a Buy at Jefferies
3/7
05:39 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/7
05:39 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
3/7
08:17 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
3/7
08:17 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
3/7
06:57 am
bpmc
Blueprint Medicines initiated with an Outperform at Scotiabank
Low
Report
Blueprint Medicines initiated with an Outperform at Scotiabank
3/7
06:57 am
bpmc
Blueprint Medicines initiated with an Outperform at Scotiabank
Low
Report
Blueprint Medicines initiated with an Outperform at Scotiabank
2/28
10:04 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
Medium
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
2/28
10:04 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
Medium
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
2/14
10:09 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
2/14
10:09 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
2/14
09:53 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/14
09:53 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/14
08:07 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.